chr1-93996161-C-A

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 3P and 20B. PM1PP2BP4_StrongBP6_Very_StrongBA1

The NM_000350.3(ABCA4):​c.6764G>T​(p.Ser2255Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0619 in 1,613,784 control chromosomes in the GnomAD database, including 10,691 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 4974 hom., cov: 33)
Exomes 𝑓: 0.051 ( 5717 hom. )

Consequence

ABCA4
NM_000350.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14O:1

Conservation

PhyloP100: 0.742

Publications

41 publications found
Variant links:
Genes affected
ABCA4 (HGNC:34): (ATP binding cassette subfamily A member 4) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This protein is a retina-specific ABC transporter with N-retinylidene-PE as a substrate. It is expressed exclusively in retina photoreceptor cells, and the gene product mediates transport of an essental molecule, all-trans-retinal aldehyde (atRAL), across the photoreceptor cell membrane. Mutations in this gene are found in patients diagnosed with Stargardt disease, a form of juvenile-onset macular degeneration. Mutations in this gene are also associated with retinitis pigmentosa-19, cone-rod dystrophy type 3, early-onset severe retinal dystrophy, fundus flavimaculatus, and macular degeneration age-related 2. [provided by RefSeq, Sep 2019]
ABCA4 Gene-Disease associations (from GenCC):
  • ABCA4-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • cone-rod dystrophy 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • severe early-childhood-onset retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • retinitis pigmentosa 19
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Stargardt disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 8 uncertain in NM_000350.3
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 578 curated pathogenic missense variants (we use a threshold of 10). The gene has 28 curated benign missense variants. Gene score misZ: -0.65813 (below the threshold of 3.09). Trascript score misZ: 1.3628 (below the threshold of 3.09). GenCC associations: The gene is linked to cone-rod dystrophy 3, retinitis pigmentosa 19, ABCA4-related retinopathy, severe early-childhood-onset retinal dystrophy, cone-rod dystrophy, Stargardt disease, retinitis pigmentosa.
BP4
Computational evidence support a benign effect (MetaRNN=1.2466311E-4).
BP6
Variant 1-93996161-C-A is Benign according to our data. Variant chr1-93996161-C-A is described in ClinVar as Benign. ClinVar VariationId is 99494.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.474 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCA4NM_000350.3 linkc.6764G>T p.Ser2255Ile missense_variant Exon 49 of 50 ENST00000370225.4 NP_000341.2 P78363Q6AI28
ABCA4NM_001425324.1 linkc.6542G>T p.Ser2181Ile missense_variant Exon 48 of 49 NP_001412253.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCA4ENST00000370225.4 linkc.6764G>T p.Ser2255Ile missense_variant Exon 49 of 50 1 NM_000350.3 ENSP00000359245.3 P78363

Frequencies

GnomAD3 genomes
AF:
0.165
AC:
25160
AN:
152116
Hom.:
4967
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.480
Gnomad AMI
AF:
0.0943
Gnomad AMR
AF:
0.0925
Gnomad ASJ
AF:
0.0616
Gnomad EAS
AF:
0.0227
Gnomad SAS
AF:
0.0553
Gnomad FIN
AF:
0.00518
Gnomad MID
AF:
0.134
Gnomad NFE
AF:
0.0411
Gnomad OTH
AF:
0.146
GnomAD2 exomes
AF:
0.0715
AC:
17958
AN:
251210
AF XY:
0.0630
show subpopulations
Gnomad AFR exome
AF:
0.494
Gnomad AMR exome
AF:
0.0617
Gnomad ASJ exome
AF:
0.0682
Gnomad EAS exome
AF:
0.0270
Gnomad FIN exome
AF:
0.00578
Gnomad NFE exome
AF:
0.0400
Gnomad OTH exome
AF:
0.0660
GnomAD4 exome
AF:
0.0511
AC:
74676
AN:
1461550
Hom.:
5717
Cov.:
31
AF XY:
0.0499
AC XY:
36308
AN XY:
727086
show subpopulations
African (AFR)
AF:
0.499
AC:
16711
AN:
33460
American (AMR)
AF:
0.0657
AC:
2938
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0702
AC:
1836
AN:
26136
East Asian (EAS)
AF:
0.0230
AC:
912
AN:
39700
South Asian (SAS)
AF:
0.0506
AC:
4367
AN:
86256
European-Finnish (FIN)
AF:
0.00682
AC:
363
AN:
53252
Middle Eastern (MID)
AF:
0.126
AC:
725
AN:
5766
European-Non Finnish (NFE)
AF:
0.0381
AC:
42391
AN:
1111882
Other (OTH)
AF:
0.0734
AC:
4433
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
3506
7011
10517
14022
17528
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1840
3680
5520
7360
9200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.166
AC:
25199
AN:
152234
Hom.:
4974
Cov.:
33
AF XY:
0.160
AC XY:
11934
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.480
AC:
19914
AN:
41482
American (AMR)
AF:
0.0922
AC:
1411
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0616
AC:
214
AN:
3472
East Asian (EAS)
AF:
0.0226
AC:
117
AN:
5180
South Asian (SAS)
AF:
0.0541
AC:
261
AN:
4822
European-Finnish (FIN)
AF:
0.00518
AC:
55
AN:
10624
Middle Eastern (MID)
AF:
0.144
AC:
42
AN:
292
European-Non Finnish (NFE)
AF:
0.0411
AC:
2793
AN:
68030
Other (OTH)
AF:
0.145
AC:
306
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
806
1612
2419
3225
4031
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
224
448
672
896
1120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0760
Hom.:
6658
Bravo
AF:
0.186
TwinsUK
AF:
0.0361
AC:
134
ALSPAC
AF:
0.0376
AC:
145
ESP6500AA
AF:
0.478
AC:
2105
ESP6500EA
AF:
0.0465
AC:
400
ExAC
AF:
0.0802
AC:
9739
Asia WGS
AF:
0.0660
AC:
231
AN:
3478
EpiCase
AF:
0.0498
EpiControl
AF:
0.0510

ClinVar

Significance: Benign
Submissions summary: Benign:14Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4Other:1
-
Retina International
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

-
Department of Ophthalmology and Visual Sciences Kyoto University
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 28, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 13, 2011
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Aug 25, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinitis Pigmentosa, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Stargardt Disease, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ABCA4-related disorder Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Cone-Rod Dystrophy, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinal dystrophy Benign:1
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Severe early-childhood-onset retinal dystrophy;C1858806:Cone-rod dystrophy 3;C1866422:Retinitis pigmentosa 19;C3495438:Age related macular degeneration 2 Benign:1
Jul 15, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Macular degeneration Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
1.7
DANN
Benign
0.69
DEOGEN2
Benign
0.26
T;T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.35
N
LIST_S2
Benign
0.048
T;T
MetaRNN
Benign
0.00012
T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
0.34
.;N
PhyloP100
0.74
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.99
.;N
REVEL
Benign
0.20
Sift
Benign
0.13
.;T
Sift4G
Benign
0.089
T;D
Polyphen
0.0
.;B
Vest4
0.026
MPC
0.099
ClinPred
0.0043
T
GERP RS
-2.0
Varity_R
0.085
gMVP
0.22
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6666652; hg19: chr1-94461717; COSMIC: COSV64672127; API